What explains such a rapid rise in price for a drug that has been off-patent for years?
In a recent Wall St. Journal Op-Ed, former FDA associate commissioner Dr. Scott Gottlieb explains how the several-year-duration shortages of common generic drugs came about. That would be through excessive regulation, and not because of Big Pharma greed, which Hillary Clinton wants you to believe.